ABSTRACT
ABSTRACT: Americium-241 is a significant radiation hazard at facilities that handle or reprocess spent nuclear fuels. An inhalation intake model for 241Am was developed using autopsy data obtained from former workers at the Radiochemical and Plutonium Production Plants at the Mayak Production Association (Mayak PA), Ozyorsk, Russia. Accumulation of 241Am in the body can occur though direct exposure to 241Am (termed here "exogenous" exposures), usually as an inhaled aerosol, or though exposure to 241Pu that decays inside the body to 241Am (termed here "endogenous" exposures). Metabolism of endogenous and exogenous 241Am can differ, with endogenous 241Am being initially related to the behavior of 241Pu. For the model, it was assumed that intakes of 241Am and 241Pu were functionally associated with intakes of 239Pu. The current Mayak Worker Dosimetry System model (MWDS-2008) was used to describe metabolism of plutonium and americium in the respiratory tract. The ICRP-30 model was used for the gastrointestinal tract, the ICRP-67 model was used for metabolism after absorption into the blood for americium, and the "Leggett modification" of the ICRP-67 model for plutonium was used for systemic, non-pulmonary organs. The proposed inhalation intake model for americium provides estimates for internal doses from 241Am from both exogenous and endogenous sources.
